ABBISKO CAYMAN LTD revenue for the last year amounted to 20.97 M HKD, the most of which — 21.06 M HKD — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 27.34 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought ABBISKO CAYMAN LTD 21.06 M HKD, and the year before that — 27.34 M HKD.